Showing 121 - 140 of 240 results
In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth. However, it is the secondary particles of lower energies created when galactic and cosmic radiation interacts with shielding that is of concern for astronauts.
In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.
ANSTO is a partner on the National Space Qualification Network (NSQN) led by the Australian National University (ANU) that will transform Australia into a world-leading space centre by enhancing facilities to test payloads, components, and hardware prior to their use in harsh environments of space.
ANSTO works in partnerships and collaborative ventures with national and international organisations. Partner with ANSTO.
Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.
Detailed data on ANSTO electricity use and CO2 emissions for FY2022 - FY2023
ANSTO provides access to specialised facilities and capabilities by application. Please ensure that you contact the relevant ANSTO scientist for advice before submitting a proposal.
Guide to successful proposals and experiments at the Powder Diffraction beamline.
New class of conducting materials found for potential use in next generation fuel cells and other applications.
ANSTO to contribute to research on Next Gen Nuclear Energy Systems
Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
Two Australian scientists have been appointed to assist with the development of a $500 million-dollar synchrotron facility in Mexico, the first and largest project of its kind.
Cracking the code for crop nutrition and food quality with X-ray fluorescence microscopy.
Professor Elliot Gilbert and Dr Norman Booth have received awards from the Australian Neutron Beam Users Group at the 2021 ANSTO Users Meeting